S100A8 and cancer: The second point to consider is that HRG was downregulated in our patients with brain-metastatic lung cancer (Figure 4C), which would lead to the circumstance that S100A8/A9 was dominant in the cancer milieu at the onset site as well as in the cancer premetastatic environments in the remote organs.